N/A
N=210
Integrating Care After Exacerbation of COPD
Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT02021955 ↗Enrolled (actual)
210
Serious AEs
43.2%
Results posted
Jun 2021
Primary outcome: Primary: Number of Patients With Hospital Re-admission and Mortality — 84; 61 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- guideline treatment recommendations (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Nov 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients With Hospital Re-admission and Mortality |
84; 61 | — |
| PRIMARY COPD-related Patient Quality-of-life (Clinical COPD Questionnaire) |
3.50; 2.97 | — |
| SECONDARY Patients Participants' General Health Status (Veterans RAND 12 Item Health Survey ) Physical Component Score (VR-12 PCS) |
29.92; 33.25 | — |
Summary
This clinical trial is designed to determine whether an intervention that provides information to primary care providers about gaps in care for their patients recently discharged from hospital for COPD can reduce hospital re-admissions and mortality and improve their patients' quality-of-life.
Eligibility Criteria
Inclusion Criteria
Providers:
- Primary care provider (MD, NP, PA) from VA Puget Sound or Boise VA.
- Willingness to participate in the informed consent process and complete interviews and questionnaires.
Patients:
- Having a provider that is participating in this clinical trial.
- Discharged alive with either a primary discharge diagnosis of COPD or acute respiratory failure with a secondary diagnosis of COPD.
- Willing and able to participate in the informed consent process and complete interviews and questionnaires.
Exclusion Criteria
Providers: none
Patients:
- Having previously participated in the study.
- Significant cognitive dysfunction, language barrier, or severe psychiatric disorder that would preclude completing the questionnaires.
Data sourced from ClinicalTrials.gov (NCT02021955). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.